Key result
Cardiac magnetic resonance unmasked a high risk of sudden cardiac death in a 24-year-old man with apical hypertrophic cardiomyopathy, compared to low-intermediate risk by traditional assessment.
Why the study?
CMR has been implemented to refine the daunting task of establishing sudden cardiac death risk in hypertrophic cardiomyopathy patients.
Does cardiac magnetic resonance (CMR) improve sudden cardiac death (SCD) risk stratification compared to traditional assessment in patients with hypertrophic cardiomyopathy?
Case Report (n=1)
Does cardiac magnetic resonance (CMR) improve sudden cardiac death (SCD) risk stratification compared to traditional assessment in patients with hypertrophic cardiomyopathy?
Cardiac magnetic resonance provides critical added value over traditional imaging for accurate sudden cardiac death risk stratification in patients with hypertrophic cardiomyopathy.
Case suggests CMR may refine SCD risk stratification in apical HCM; leaves open validation in larger cohorts before practice change.
Cardiac magnetic resonance (CMR) has been recently implemented in clinical practice to refine the daunting task of establishing the risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). We present an exemplificative case highlighting the practical clinical utility of this imaging modality in a 24-year-old man newly diagnosed with an apical HCM. CMR was essential in unmasking a high risk of SCD, which appeared low-intermediate after traditional risk assessment. A discussion examines the essential role of CMR in guiding the patient's therapy and underlines the added value of CMR, including novel and potential CMR parameters, compared to traditional imaging assessment for SCD risk stratification.
No takes yet. Share an insight, caveat, or question.
Stankowski et al. (2023) conducted a case report in Hypertrophic cardiomyopathy (HCM) (n=1). Cardiac magnetic resonance (CMR) vs. Traditional imaging assessment was evaluated on Sudden cardiac death (SCD) risk stratification. Cardiac magnetic resonance unmasked a high risk of sudden cardiac death in a 24-year-old man with apical hypertrophic cardiomyopathy, compared to low-intermediate risk by traditional assessment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: